You just read:

European Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA®▼ (edoxaban)

News provided by

Daiichi Sankyo

Oct 12, 2019, 04:48 ET